Pfizer Inc. (PFE)
29.58
+0.14
(+0.48%)
USD |
NYSE |
Oct 16, 16:00
29.59
+0.01
(+0.03%)
After-Hours: 20:00
Pfizer Free Cash Flow (Quarterly) : 302.00M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 302.00M |
| March 31, 2026 | 2.179B |
| December 31, 2025 | 4.504B |
| September 30, 2025 | 4.001B |
| June 30, 2025 | -1.20B |
| March 31, 2025 | 1.771B |
| December 31, 2024 | 5.804B |
| September 30, 2024 | 6.063B |
| June 30, 2024 | -2.419B |
| March 31, 2024 | 387.00M |
| December 31, 2023 | 4.196B |
| September 30, 2023 | 2.646B |
| June 30, 2023 | -2.121B |
| March 31, 2023 | 72.00M |
| December 31, 2022 | 7.581B |
| September 30, 2022 | 9.094B |
| June 30, 2022 | 7.418B |
| March 31, 2022 | 5.898B |
| December 31, 2021 | 4.912B |
| September 30, 2021 | 10.22B |
| June 30, 2021 | 10.74B |
| March 31, 2021 | 3.992B |
| December 31, 2020 | 4.812B |
| September 30, 2020 | 1.582B |
| June 30, 2020 | 3.099B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.684B |
| December 31, 2019 | 3.043B |
| September 30, 2019 | 3.848B |
| June 30, 2019 | 2.023B |
| March 31, 2019 | 1.08B |
| December 31, 2018 | 3.946B |
| September 30, 2018 | 4.697B |
| June 30, 2018 | 3.391B |
| March 31, 2018 | 1.597B |
| December 31, 2017 | 6.301B |
| September 30, 2017 | 4.307B |
| June 30, 2017 | 2.744B |
| March 31, 2017 | 1.233B |
| December 31, 2016 | 4.983B |
| September 30, 2016 | 4.303B |
| June 30, 2016 | 3.108B |
| March 31, 2016 | 1.508B |
| December 31, 2015 | 4.051B |
| September 30, 2015 | 4.699B |
| June 30, 2015 | 3.828B |
| March 31, 2015 | 438.00M |
| December 31, 2014 | 5.001B |
| September 30, 2014 | 3.903B |
| June 30, 2014 | 3.759B |
| March 31, 2014 | 2.637B |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Johnson & Johnson | 7.295B |
| Eli Lilly & Co. | 4.475B |
| Merck & Co., Inc. | 4.477B |
| Bristol Myers Squibb Co. | 3.088B |
| Viatris, Inc. | 328.00M |